Carisma Therapeutics, Inc.CARMNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank31
Studio
Year-over-Year Change

Price-to-book ratio

Percentile
P31
Within normal range
vs 3Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
2024-0.62-116.8%
20233.70+218.5%
2022-3.12-461.0%
20210.87+105.0%
2020-17.30-388.4%
2019-3.54-278.5%
20181.98+69.1%
20171.17+12.8%
20161.04-65.5%
20153.02-